Weekly Injectable Treatment for Parkinson's Disease
Parkinson's disease, the second most common neurodegenerative disorder after Alzheimer's, affects over 10 million people globally, with symptoms typically emerging after age 50.
Patients often rely on multiple daily tablets to manage symptoms like tremors, stiffness, and balance issues.
Australian scientists have developed a potential weekly injectable treatment, which could significantly improve the quality of life for those with Parkinson's if proven safe and effective.
A long-acting therapy could significantly improve the quality of life for those with Parkinson’s.
- The treatment is an in-situ forming implant system designed to provide sustained delivery of levodopa and carbidopa.
- Levodopa and carbidopa are two standard drugs used to treat Parkinson's disease symptoms.
Author's summary: New injectable treatment may transform Parkinson's disease management.
More News
- Staffordshire Leader Reacts to "Squandered" Billions of Taxpayers' Money on Asylum Hotels - Staffordshire County Council Newsroom
- Biopic reintroduces female revolutionary hero - BusinessWorld Online
- READY, FIRE, AIM: Fly Me to the Moon – Pagosa Daily Post News Events & Video for Pagosa Springs Colorado
- West Indies ease past Bangladesh in first T20I
- Deandre Ayton claims Los Angeles Lakers superstars ‘troll him’ to get him going
- Why Hiring a Fishers Personal Injury Lawyer Is Key After a Car Accident, Slip, or Dog Bite | NorthPennNow
- Liam Hemsworth vs. Gabriella Brooks: Who Has the Higher Net Worth?
- Jensen Ackles back on 'Tracker' 3.2 to amp up the suspense
- Star Trek: Zachary Quinto Reprises Spock Role in Unexpected Way
- Pirates Listed as Potential Fit for Trent Grisham, Luis Arráez and Other Top Free Agents